Shares of Sino Biopharmaceutical were the best performing among the 21 Hong Kong-listed companies that made it to Forbes’ ‘Best Over a Billion’ list. Photo: Shutterstock
21 Hong Kong-listed firms in Forbes’ inaugural list of top Asian corporates, but share prices tell a different story
- Forbes’ inaugural ‘Best Over a Billion’ list comprises Asia’s top 200 companies with revenues of over US$1 billion
- Average share price loss for the 21 Hong Kong companies in the list was 12.68 per cent against the Hang Seng Index decline of 7.17 per cent
Topic |
Investing
Shares of Sino Biopharmaceutical were the best performing among the 21 Hong Kong-listed companies that made it to Forbes’ ‘Best Over a Billion’ list. Photo: Shutterstock